Key points from article :
Iimplantable, microchip-based device may soon replace the injections and pills now needed to treat chronic diseases.
Microchips Biotech partnering with Teva Pharmaceutical to fund clinical trials.
The studies were published in the Annals of Internal Medicine, Science Translational Medicine and Nature journals.